Statistically significant decrease in novel biomarkers associated with a high risk of cardiovascular events
Results further support PBI-4050’s pharmacological activity and clinical benefits in patients
LAVAL, QC, March 22, 2016 /CNW Telbec/ – ProMetic Life Sciences Inc. (TSX:…